Henk Doude News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma

/PRNewswire/ Hansa Biopharma, "Hansa" (NASDAQ Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that.

United statesHansa biopharmaPrnewswire hansa biopharmaStephanie kenneyKlaus sindahlMatthew shaulisHenk doude van troostwijkImmunology for the international developedHansa biopharma incVp global corporate affairsChief commercial officerHenk doudeVice presidentCommercial excellenceInternational developed marketsNorth america oncology

Hansa Biopharma announces reimbursement in the Netherlands of Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

Hansa Biopharma announces reimbursement in the Netherlands of Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomHansa biopharmaPrnewswire hansa biopharmaKlaus sindahlHenk doude van troostwijkKatja margellEuropean unionEuropean medicines agencyErasmus medical centerEuropean medicines agency priorityHead of corporate communicationsNasdaq stockholmHenk doudeSenior vice presidentChief commercial officerInvestor relations